Department of Anesthesiology
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is H  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H
Hemmings HC, Nairn AC, Greengard P.  1984.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. II. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor 1.. J Biol Chem. 259(23):14491-7.
Hemmings HC, Rosenberg AD, Mahajan RP, Webster NR.  2012.  The 2012 BJA/PGA supplement: a selection of seven educational reviews.. Br J Anaesth. 109 Suppl 1:i1-i2.
Hemmings HC, Mantz J.  2008.  Xenon and the pharmacology of fear.. Anesthesiology. 109(6):954-5.
Hemmings HC, Adamo AI.  1997.  Effect of halothane on conventional protein kinase C translocation and down-regulation in rat cerebrocortical synaptosomes.. Br J Anaesth. 78(2):189-96.
Hemmings HC, Nairn AC, McGuinness TL, Huganir RL, Greengard P.  1989.  Role of protein phosphorylation in neuronal signal transduction.. FASEB J. 3(5):1583-92.
Hemmings HC, Hunter JM.  2017.  Landmarks in UK anaesthesia.. Br J Anaesth. 119(6):1073-1074.
Hemmings HC, Mackie K.  2011.  The rivers of Lethe and Mnemosyne converge: propofol and memory consolidation.. Anesthesiology. 114(6):1277-9.
Hemmings HC.  2022.  Turning the page on 2021: an eventful year for the British Journal of Anaesthesia.. Br J Anaesth. 128(1):1-3.
Hemmings HC, Antognini JF.  2006.  Do general anesthetics add up? Anesthesiology. 104(6):1120-2.
Hemmings HC, Nairn AC, Greengard P.  1986.  Protein kinases and phosphoproteins in the nervous system.. Res Publ Assoc Res Nerv Ment Dis. 64:47-69.
Hemmings HC, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL.  2005.  Emerging molecular mechanisms of general anesthetic action.. Trends Pharmacol Sci. 26(10):503-10.
Hemmings HC, Jevtovic-Todorovic V.  2013.  Special issue on anaesthetic neurotoxicity and neuroplasticity.. Br J Anaesth. 110 Suppl 1:i1-2.
Hemmings, Jr. HC, Egan TD.  2019.  Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application. :994.
Hemmings HC.  2009.  Sodium channels and the synaptic mechanisms of inhaled anaesthetics.. Br J Anaesth. 103(1):61-9.
Hemmings HC.  1998.  General anesthetic effects on protein kinase C.. Toxicol Lett. 100-101:89-95.
Hemmings HC, Greengard P.  1989.  ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Purification and characterization of the protein from bovine caudate nucleus.. J Neurosci. 9(3):851-64.
Hemmings HC, Nairn AC, Aswad DW, Greengard P.  1984.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus.. J Neurosci. 4(1):99-110.
Hemmings HC, Adamo AI.  1994.  Effects of halothane and propofol on purified brain protein kinase C activation.. Anesthesiology. 81(1):147-55.
Hemmings HC, Mahajan R, Webster NR.  2016.  The 2016 BJA/PGA special issue: a selection of six educational reviews.. Br J Anaesth. 117(suppl 3):i1-i2.
Hemmings HC, Greengard P.  1986.  DARPP-32, a dopamine-regulated phosphoprotein.. Prog Brain Res. 69:149-59.
Hemmings HC, Riegelhaupt PM, Kelz MB, Solt K, Eckenhoff RG, Orser BA, Goldstein PA.  2019.  Towards a Comprehensive Understanding of Anesthetic Mechanisms of Action: A Decade of Discovery.. Trends Pharmacol Sci. 40(7):464-481.
Hemmings HC, Lambert DG.  2023.  Celebrating the first centenary of the British Journal of Anaesthesia: a century of discovery and dissemination.. Br J Anaesth. 130(1):1-2.
Hemmings HC.  2004.  Neuroprotection by Na+ channel blockade.. J Neurosurg Anesthesiol. 16(1):100-1.
Hemmings HC, Girault JA, Williams KR, LoPresti MB, Greengard P.  1989.  ARPP-21, a cyclic AMP-regulated phosphoprotein (Mr = 21,000) enriched in dopamine-innervated brain regions. Amino acid sequence of the site phosphorylated by cyclic AMP in intact cells and kinetic studies of its phosphorylation in vitro.. J Biol Chem. 264(13):7726-33.
Hemmings HC, Greengard P, Tung HY, Cohen P.  1984.  DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.. Nature. 310(5977):503-5.